Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobutaka Fujii

Showing results (1-10 of 294) with videos related to

Pageof 30
Sort By:
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|December 7, 2007
[Peptide-lead drug discovery]Shinya Oishi, Nobutaka Fujii
Biopolymers|June 9, 2016
Neuropeptide derivatives to regulate the reproductive axis: Kisspeptin receptor (KISS1R) ligands and neurokinin-3 receptor (NK3R) ligandsShinya Oishi, Nobutaka Fujii
Expert Opinion on Therapeutic Targets|November 23, 2005
The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritisHirokazu Tamamura, Nobutaka Fujii
Organic & Biomolecular Chemistry|April 21, 2012
Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4)Shinya Oishi, Nobutaka Fujii
Current Drug Targets. Infectious Disorders|June 8, 2004
Two orthogonal approaches to overcome multi-drug resistant HIV-1s: development of protease inhibitors and entry inhibitors based on CXCR4 antagonistsHirokazu Tamamura, Nobutaka Fujii
Expert Opinion on Investigational Drugs|January 31, 2003
The therapeutic potential of CXCR4 antagonists in the treatment of HIVNobutaka Fujii, Hideki Nakashima, Hirokazu Tamamura
Mini Reviews in Medicinal Chemistry|October 5, 2006
The chemokine receptor CXCR4 as a therapeutic target for several diseasesHirokazu Tamamura, Hiroshi Tsutsumi, Nobutaka Fujii
Current HIV Research|October 28, 2005
Development of anti-HIV agents targeting dynamic supramolecular mechanism: entry and fusion inhibitors based on CXCR4/CCR5 antagonists and gp41-C34-remodeling peptidesHirokazu Tamamura, Akira Otaka, Nobutaka Fujii
Seminars in Cancer Biology|December 17, 2008
Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumorsHyunsuk Shim, Shinya Oishi, Nobutaka Fujii
Perspectives in Medicinal Chemistry|September 30, 2009
Exploratory studies on development of the chemokine receptor CXCR4 antagonists toward downsizingHirokazu Tamamura, Hiroshi Tsutsumi, Wataru Nomura, et al.
Pageof 30

Showing results (1-10 of 294) with videos related to

Sort By:
Pageof 30
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|December 7, 2007
[Peptide-lead drug discovery]Shinya Oishi, Nobutaka Fujii
Biopolymers|June 9, 2016
Neuropeptide derivatives to regulate the reproductive axis: Kisspeptin receptor (KISS1R) ligands and neurokinin-3 receptor (NK3R) ligandsShinya Oishi, Nobutaka Fujii
Expert Opinion on Therapeutic Targets|November 23, 2005
The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritisHirokazu Tamamura, Nobutaka Fujii
Organic & Biomolecular Chemistry|April 21, 2012
Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4)Shinya Oishi, Nobutaka Fujii
Current Drug Targets. Infectious Disorders|June 8, 2004
Two orthogonal approaches to overcome multi-drug resistant HIV-1s: development of protease inhibitors and entry inhibitors based on CXCR4 antagonistsHirokazu Tamamura, Nobutaka Fujii
Expert Opinion on Investigational Drugs|January 31, 2003
The therapeutic potential of CXCR4 antagonists in the treatment of HIVNobutaka Fujii, Hideki Nakashima, Hirokazu Tamamura
Mini Reviews in Medicinal Chemistry|October 5, 2006
The chemokine receptor CXCR4 as a therapeutic target for several diseasesHirokazu Tamamura, Hiroshi Tsutsumi, Nobutaka Fujii
Current HIV Research|October 28, 2005
Development of anti-HIV agents targeting dynamic supramolecular mechanism: entry and fusion inhibitors based on CXCR4/CCR5 antagonists and gp41-C34-remodeling peptidesHirokazu Tamamura, Akira Otaka, Nobutaka Fujii
Seminars in Cancer Biology|December 17, 2008
Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumorsHyunsuk Shim, Shinya Oishi, Nobutaka Fujii
Perspectives in Medicinal Chemistry|September 30, 2009
Exploratory studies on development of the chemokine receptor CXCR4 antagonists toward downsizingHirokazu Tamamura, Hiroshi Tsutsumi, Wataru Nomura, et al.
Pageof 30